Xperi (XPER) Adverse Ruling May Not Prevent Upside - BWS Financial
Tweet Send to a Friend
BWS Financial analyst Hamed Khorsand reiterated a Buy rating and $26.00 price target on Xperi (NASDAQ: XPER) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


